The first thing you notice about soil diagnostics is the bottleneck. It’s a manual, expert-driven process, where a lab technician might spend hours peering through a microscope to identify a single parasitic nematode in a sample. The second thing you notice is the scale of the problem: 70% of soils worldwide are degraded, costing an estimated $10.6 trillion per year [Veridi Technologies, retrieved 2026]. Veridi Technologies, a startup based in The Hague, is betting that the path to fixing the first problem is the only way to address the second. Its wedge is a piece of hardware called the Nemascope, an AI-powered automated microscope that identifies soil pathogens with a reported 96% accuracy [WUR, retrieved 2026]. The company is selling this not as a lab instrument, but as a SaaS-like diagnostics service, with no upfront costs and a model built for volume.
A hardware wedge into a software business
Veridi’s core bet is that automation can turn a niche, expert-dependent service into a scalable, data-driven business. The company’s platform combines precision mechatronics, computer vision, and deep learning to analyze soil samples. It focuses specifically on nematodes, microscopic worms that are both a key indicator of soil biodiversity and a major destroyer of crops. By automating the identification process, Veridi aims to deliver high-throughput, high-accuracy diagnostics that can be plugged directly into existing agronomic models for farm management advice [AgFunderNews, retrieved 2026]. The business model follows the automation thesis: a ‘no upfront costs, maximum flexibility’ pay-per-use structure that lowers the barrier for adoption by agricultural testing labs, agronomy services, and larger farming operations [Veridi Technologies, retrieved 2026].
Why the EIC wrote a €2.5 million check
The most significant validation of Veridi’s approach to date isn’t from a venture fund, but from a public grantor. In 2023, the company was awarded up to €2.5 million in financing by the European Innovation Council (EIC) Accelerator program [The Hague - Stories of Purpose, Oct 2023]. This non-dilutive capital is earmarked for solving what the EIC frames as a €50 billion per year soil degradation problem in the EU. For a startup with relatively modest disclosed equity funding,PitchBook notes a total of $56.4K [PitchBook, retrieved 2026],the grant represents a substantial war chest and a powerful signal. It suggests that European institutions see automated soil health monitoring not just as a commercial opportunity, but as a critical piece of agricultural and environmental infrastructure.
The company’s early backing also includes agrifood-tech specialist THRIVE (SVG Ventures|THRIVE), which led a seed round in 2022, alongside investors like Silverstrand Capital and RootCamp [Tracxn, retrieved 2026]. A more recent $1 million seed round was closed in February 2026, led by the WNY Impact Investment Fund [Tracxn, Mar 2026]. The founding team brings a blend of deep tech and entrepreneurial experience. Co-founder and CEO Ziad Matar has over three decades in technology, with leadership roles at Ericsson and Qualcomm, and a parallel track as a serial entrepreneur and advisor [LinkedIn/wirelessly, retrieved 2026]. Co-founder and CTO Richard Janissen provides the scientific and technical depth, focusing on bio-assays and imaging methods [nl.linkedin.com/in/richardjanissen, retrieved 2026]. They launched the company with support from Joachim Schneider, the former CEO of Bayer Vegetable Seeds, adding early industry credibility [AgFunderNews, retrieved 2026].
The traction and the unanswered questions
Public traction metrics for early-stage deep tech companies like Veridi are often light on customer names and heavy on technical validation. The company’s primary proof points are its accuracy claims and its grant win. Its Nemascope platform has demonstrated 96% accuracy in identifying specific nematode species in validation studies [WUR, retrieved 2026], and the company claims it is the first and only to diagnose nematodes at 95% accuracy via an AI-powered microscopy platform [b2match.com, retrieved 2026]. The recent launch of its NEMASCOPE® product at a major European nematology conference in June 2026 marks its formal commercial entry [Veridi Technologies, June 2026].
However, the path from technical validation to commercial scale in agriculture is long and fraught with specific risks. The procurement cycle for agricultural inputs and services is conservative, and displacing entrenched lab services requires proving not just accuracy, but reliability, speed, and cost savings over time. The ‘no upfront cost’ model aids adoption but could pressure early unit economics and delay revenue recognition. Furthermore, while nematodes are a strategic wedge, the ultimate market is broader soil health analytics. Expanding the platform’s diagnostic capabilities beyond nematodes to other pathogens and biodiversity indicators will require continued R&D investment.
Who buys this, and who else sells it
The ideal customer profile is not the individual farmer, but the agricultural service provider. This includes independent soil testing laboratories, the in-house labs of large agribusinesses or cooperatives, and agronomy consulting firms. These are the entities that currently perform manual diagnostics and would gain immediate efficiency from an automated, high-volume service. For them, the value proposition is clear: reduce labor costs, increase sample throughput, and generate standardized, data-rich reports that can inform precision farming decisions.
Veridi’s realistic competitive set is bifurcated. On one side are traditional manual lab services, which it aims to disrupt with automation and scale. On the other are emerging tech-enabled competitors.
- LandScan.
- Manual laboratory services. The entrenched, fragmented market of regional and national soil testing labs that rely on expert technicians.
- Broad-spectrum agtech platforms. Larger agricultural technology companies that may add soil pathogen diagnostics as a module within a suite of farm management tools.
Veridi’s defensibility rests on the integrated hardware-software stack and the proprietary dataset of annotated microscopic images its AI models are trained on. The next twelve months will be about moving from grant-funded development to commercial proof. Key milestones to watch include the announcement of its first named commercial customers, the volume of samples processed through its platform, and any partnerships with agricultural distributors or research institutions to validate its data in field trials. If the company can demonstrate that labs are willing to switch their workflow, it will have proven that its automated wedge can hold.
Sources
- [Veridi Technologies, retrieved 2026] Company website | https://veridi.tech/
- [WUR, retrieved 2026] Nemascope validation | https://veridi.tech/news
- [AgFunderNews, retrieved 2026] Article on Veridi Technologies | https://veridi.tech/news
- [The Hague - Stories of Purpose, Oct 2023] EIC Accelerator grant announcement | https://storiesofpurpose.thehague.com/impact/veridi-technologies-awarded-25-million-euros
- [PitchBook, retrieved 2026] Company funding profile | https://pitchbook.com/profiles/company/516032-83
- [Tracxn, retrieved 2026] Company profile and funding rounds | https://tracxn.com/d/companies/veridi-technologies/__nxWnlsGiw_YbcY4ZcfMyBDmu1R4B54Dm3mP-RFr14ag
- [Tracxn, Mar 2026] $1M seed round | https://platform.tracxn.com/a/d/company/61dc4860f5baa84d3e11907c/veridi%20technologies
- [LinkedIn/wirelessly, retrieved 2026] Ziad Matar profile | https://es.linkedin.com/in/wirelessly
- [nl.linkedin.com/in/richardjanissen, retrieved 2026] Richard Janissen profile | https://nl.linkedin.com/in/richardjanissen
- [b2match.com, retrieved 2026] Company description and accuracy claims | https://veridi.tech/news